Succinate dehydrogenase


Succinate dehydrogenase
succinate dehydrogenase (ubiquinone)
Succinate Dehydrogenase.jpg
Subunits: SdhA, SdhB, SdhC and SdhD
Identifiers
EC number 1.3.5.1
CAS number 9028-11-9
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / EGO

Succinate dehydrogenase or succinate-coenzyme Q reductase (SQR) or Complex II is an enzyme complex, bound to the inner mitochondrial membrane of mammalian mitochondria and many bacterial cells. It is the only enzyme that participates in both the citric acid cycle and the electron transport chain.[1]

In step 8 of the citric acid cycle, SQR catalyzes the oxidation of succinate to fumarate with the reduction of ubiquinone to ubiquinol. This occurs in the inner mitochondrial membrane by coupling the two reactions together.

Contents

Structure

Image 3: The structure of SQR in a phospholipid membrane. SdhA, SdhB, SdhC and SdhD.
Image 4: Binding Site of Ubiquinone.[2]
Image 5: The oxidation of Succinate.

Subunits: Mammalian, mitochondrial, and many bacterial monomer SQRs are composed of four subunits: two hydrophilic and two hydrophobic. The first two subunits, a flavoprotein (SdhA) and an iron-sulfur protein (SdhB), are hydrophilic. SdhA contains a covalently attached flavin adenine dinucleotide (FAD) cofactor and the succinate binding site and SdhB contains three iron-sulfur clusters: [2Fe-2S], [4Fe-4S], and [3Fe-4S]. The second two subunits are hydrophobic membrane anchor subunits, SdhC and SdhD. Human mitochondria consists of two distinct isoforms of SdhA (Fp subunits type I and type II), these isoforms are also found in Ascaris suum and Caenorhabditis elegans.[3] The subunits form a membrane-bound cytochrome b with six transmembrane helices containing one heme b group and a ubiquinone-binding site, which can be seen in Image 4. Two phospholipid molecules, one cardiolipin and one phosphatidylethanolamine, are also found in the SdhC and SdhD subunits (not shown in the image). They serve to occupy the hydrophobic space below the heme b. These subunits are displayed in image 3. SdhA is green, SdhB is teal, SdhC is fuchsia, and SdhD is yellow. Around SdhC and SdhD is a phospholipid membrane with the intermembrane space at the top of the image.[4]

Ubiquinone Binding Site: Ubiquinone’s binding site, image 4, is located in a gap composed of SdhB, SdhC, and SdhD. Ubiquinone is stabilized by the side chains of His207 of subunit B, Ser27 and Arg31 of subunit C, and Tyr83 of subunit D. The quinone ring is surrounded by Ile28 of subunit C and Pro160 of subunit B. These residues, along with Il209, Trp163, and Trp164 of subunit B, and Ser27 (C atom) of subunit C, form the hydrophobic environment of the quinone-binding pocket (not shown in the image).[5]

Succinate Binding Site: SdhA provides the binding site for the oxidation of succinate. The side chains Thr254, His354, and Arg399 of subunit A stabilize the molecule while FAD oxidizes and carries the electrons to the first of the iron-sulfur clusters, [2Fe-2S].[6] This can be seen in image 5.

Redox Centers: The succinate-binding site and ubiquinone-binding site are connected by a chain of redox centers including FAD and the iron-sulfur clusters. This chain extends over 40 Å through the enzyme monomer. All edge-to-edge distances between the centers are less than the suggested 14 Å limit for physiological electron transfer.[4] This electron transfer is demonstrated in image 8.

Mechanism

Succinate Oxidation: Little is known about the exact succinate oxidation mechanism. However, the crystal structure shows that FAD, Glu255, Arg286, and His242 of subunit A (not shown) are good candidates for the initial deprotonation step. Thereafter, there are two possible elimination mechanisms: E2 or E1cb. In the E2 elimination, the mechanism is concerted. The basic residue or cofactor deprotonates the alpha carbon, and FAD accepts the hydride from the beta carbon, oxidizing the bound succinate to fumarate--refer to image 6. In E1cb, an enolate intermediate is formed, shown in image 7, before FAD accepts the hydride. Further research is required to determine which elimination mechanism succinate undergoes in Succinate Dehydrogenase. Oxidized fumarate, now loosely bound to the active site, is free to exit the protein.

Image 6: E2 Succinate oxidation mechanism.
Image 7: E1cb Succinate oxidation mechanism.

Electron Tunneling: After the electrons are derived from succinate oxidation via FAD, they tunnel along the [Fe-S] relay until they reach the [3Fe-4S] cluster. These electrons are subsequently transferred to an awaiting ubiquinone molecule within the active site. The Iron-Sulfur electron tunneling system is shown in image 9.

Ubiquinone Reduction: The O1 carbonyl oxygen of ubiquinone is oriented at the active site (image 4) by hydrogen bond interactions with Tyr83 of subunit D. The presence of electrons in the [3Fe-4S] iron sulphur cluster induces the movement of ubiquinone into a second orientation. This facilitates a second hydrogen bond interaction between the O4 carbonyl group of ubiquinone and Ser27 of subunit C. Following the first single electron reduction step, a semiquinone radical species is formed. The second electron arrives from the [3Fe-4S] cluster to provide full reduction of the ubiquinone to ubiquinol. This mechanism of the ubiquinone reduction is shown in image 8.

Image 8: Ubiquinone reduction mechanism.
Image 9: Electron carriers of the SQR complex. FADH2, iron-sulfur centers, heme b, and ubiquinone.

Heme Functionality: Although the functionality of the heme in succinate dehydrogenase is still being researched, some studies have asserted that the first electron delivered to ubiquinone via [3Fe-4S] may tunnel back and forth between the heme and the ubiquinone intermediate. In this way, the heme cofactor acts as an electron sink. Its role is to prevent the interaction of the intermediate with molecular oxygen to produce reactive oxygen species (ROS). The heme group, relative to ubiquinone, is shown in image 4.

It has also been proposed that a gating mechanism may be in place to prevent the electrons from tunneling directly to the heme from the [3Fe-4S] cluster. A potential candidate is residue His207, which lies directly between the cluster and the heme. His207 of subunit B is in direct proximity to the [3Fe-4S] cluster, the bound ubiquinone, and the heme; and could modulate electron flow between these redox centers.[7]

Proton Transfer: To fully reduce the quinone in SQR, two electrons as well as two protons are needed. It has been argued that a water molecule (HOH39) arrives at the active site and is coordinated by His207 of subunit B, Arg31 of subunit C, and Asp82 of subunit D. The semiquinone species is protonated by protons delivered from HOH39, completing the ubiquinone reduction to ubiquinol. His207 and Asp82 most likely facilitate this process. Other studies claim that Tyr83 of subunit D is coordinated to a nearby histidine as well as the O1 carbonyl oxygen of ubiquinone. The histidine residue decreases the pKa of tyrosine, making it more suitable to donate its proton to the reduced ubiquinone intermediate.

Inhibitors

There are two distinct classes of inhibitors of complex II. Those that bind in the succinate pocket and those that bind in the ubiquinone pocket. Ubiquinone type inhibitors include carboxin and thenoyltrifluoroacetone. Succinate-analogue inhibitors include the synthetic compound malonate as well as the TCA cycle intermediates, malate and oxaloacetate. Indeed, oxaloacetate is one of the most potent inhibitors of Complex II. Why a common TCA cycle intermediate would inhibit Complex II is not entirely understood, though it may exert a protective role in minimizing reverse-electron transfer mediated production of superoxide by Complex I.[8]

Role in Disease

The fundamental role of succinate-coenzyme Q reductase in the electron transfer chain of mitochondria makes it vital in most multicellular organisms, removal of this enzyme from the genome has also been shown to be lethal at the embryonic stage in mice.

  • SdhA mutations can lead to Leigh syndrome, mitochondrial encephalopathy, and optic atrophy.
  • SdhB mutations can lead to tumorogenesis in chromaffin cells, causing hereditary paraganglioma and hereditary pheochromocytoma. Tumors tend to be malignant. It can also lead to decreased life-span and increased production of superoxide ions.
  • SdhC mutations can lead to decreased life-span, increased production of superoxide ions, hereditary paraganglioma and hereditary pheochromocytoma. Tumors tend to be benign. These mutations are uncommon.
  • SdhD mutations can lead to hereditary paraganglioma and hereditary pheochromocytoma. Tumors tend to be benign, and occur often in the head and neck regions. These mutations can also decrease life-span and increase production of superoxide ions.

Mammilian succinate dehydrogenase functions not only in mitochondrial energy generation, but also has a role in oxygen sensing and tumor suppression; and, therefore, is the object of ongoing research.

See also

SDHA

SDHB

SDHC

SDHD

References

  1. ^ Oyedotun KS, Lemire BD (March 2004). "The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase. Homology modeling, cofactor docking, and molecular dynamics simulation studies". J. Biol. Chem. 279 (10): 9424–31. doi:10.1074/jbc.M311876200. PMID 14672929. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=14672929. 
  2. ^ Pettersen EF, Goddard TD, Huang CC, et al. (October 2004). "UCSF Chimera--a visualization system for exploratory research and analysis". J Comput Chem 25 (13): 1605–12. doi:10.1002/jcc.20084. PMID 15264254. 
  3. ^ Tomitsuka E, Hirawake H, Goto Y, Taiwaki M, Harada S, Kita K (2003). "Direct evidence for two distinct forms of the flavoprotein subunit of human mitochondrial complex II (succinate-ubiquinone reductase)". J. Biochem 134 (2): 191–5. doi:10.1093/jb/mvg144. PMID 12966066. 
  4. ^ a b Yankovskaya V, Horsefield R, Törnroth S, et al. (January 2003). "Architecture of succinate dehydrogenase and reactive oxygen species generation". Science 299 (5607): 700–4. doi:10.1126/science.1079605. PMID 12560550. http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=12560550. 
  5. ^ Horsefield R, Yankovskaya V, Sexton G, et al. (March 2006). "Structural and computational analysis of the quinone-binding site of complex II (succinate-ubiquinone oxidoreductase): a mechanism of electron transfer and proton conduction during ubiquinone reduction". J. Biol. Chem. 281 (11): 7309–16. doi:10.1074/jbc.M508173200. PMID 16407191. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=16407191. 
  6. ^ Kenney WC (April 1975). "The reaction of N-ethylmaleimide at the active site of succinate dehydrogenase". J. Biol. Chem. 250 (8): 3089–94. PMID 235539. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=235539. 
  7. ^ Tran QM, Rothery RA, Maklashina E, Cecchini G, Weiner JH (October 2006). "The quinone binding site in Escherichia coli succinate dehydrogenase is required for electron transfer to the heme b". J. Biol. Chem. 281 (43): 32310–7. doi:10.1074/jbc.M607476200. PMID 16950775. http://www.jbc.org/cgi/pmidlookup?view=long&pmid=16950775. 
  8. ^ Muller FL, Liu Y, Abdul-Ghani MA, et al. (January 2008). "High rates of superoxide production in skeletal-muscle mitochondria respiring on both complex I- and complex II-linked substrates". Biochem. J. 409 (2): 491–9. doi:10.1042/BJ20071162. PMID 17916065. 
  • Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIH P41 RR-01081).

Wikimedia Foundation. 2010.

Look at other dictionaries:

  • succinate dehydrogenase — n an iron containing flavoprotein enzyme that catalyzes often reversibly the dehydrogenation of succinic acid to fumaric acid in the presence of a hydrogen acceptor and that is widely distributed esp. in animal tissues, bacteria, and yeast called …   Medical dictionary

  • succinate dehydrogenase — succinate dehydrogenase. См. сукцинатдегидрогеназа. (Источник: «Англо русский толковый словарь генетических терминов». Арефьев В.А., Лисовенко Л.А., Москва: Изд во ВНИРО, 1995 г.) …   Молекулярная биология и генетика. Толковый словарь.

  • succinate dehydrogenase — noun Date: 1962 an iron containing flavoprotein enzyme that catalyzes often reversibly the dehydrogenation of succinic acid to fumaric acid in the Krebs cycle and that is widely distributed especially in animal tissues, bacteria, and yeast called …   New Collegiate Dictionary

  • succinate dehydrogenase — noun : succinic dehydrogenase …   Useful english dictionary

  • succinate dehydrogenase — /ˌsʌkəneɪt dihaɪˈdrɒdʒəneɪz/ (say .sukuhnayt deehuy drojuhnayz) noun a key enzyme in the citric acid cycle catalysing the oxidation of succinic acid to fumaric acid …   Australian English dictionary

  • Succinate dehydrogenase complex subunit C — protein Name = succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa caption = width=250 HGNCid = 10682 Symbol = SDHC AltSymbols = PGL3 EntrezGene = 6391 OMIM = 602413 RefSeq = NM 003001 UniProt = Q99643 PDB = ECnumber =… …   Wikipedia

  • succinate dehydrogenase (ubiquinone) — suc·ci·nate de·hy·dro·gen·ase (ubiq·ui·none) (sukґsin āt de hiґdro jən ās u bikґwin ōn″) [EC 1.3.5.1] an enzyme of the oxidoreductase class that catalyzes the oxidation of succinate to fumarate, using ubiquinone as an… …   Medical dictionary

  • Dehydrogenase — A dehydrogenase (also called DHO in the literature) is an enzyme that oxidises a substrate by a reduction reaction that transfers one or more hydrides (H−) to an electron acceptor, usually NAD+/NADP+ or a flavin coenzyme such as FAD or FMN.… …   Wikipedia

  • dehydrogenase — noun Etymology: International Scientific Vocabulary Date: 1923 an enzyme that accelerates the removal of hydrogen from metabolites and its transfer to other substances compare succinate dehydrogenase …   New Collegiate Dictionary

  • dehydrogenase — Class name for those enzymes that oxidize substrates by catalyzing removal of hydrogen from metabolites (hydrogen donors) and transferring it to other substances (hydrogen acceptors), which are thus reduced; most of the oxidative enzymes… …   Medical dictionary


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.